Clinical Trial Update: Immune Spatial Features of Guselkumab Cutaneous Response [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating immune spatial features of guselkumab in cutaneous response for psoriasis of the scalp is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis of Scalp

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: University of California, San Francisco | Conditions: Psoriasis of Scalp | Phase 4 | Status: RECRUITING